A new paradigm is emerging to use real-world evidence from a variety of data sources to supplement randomized clinical trials and support regulatory decision-making for drugs and devices to better understand the patient journey.

In this white paper you’ll gain visibility to the sources, attributes, and capabilities of PINC AI™ Healthcare Data, made up of 20 years’ worth of cost, quality and operational data gleaned from 240 million unique patient encounters from 1100 sites of care. Leading pharmaceutical companies and device industries, governmental agencies, academia, healthcare insurers, and healthcare policy makers use this data for clinical, financial and outcomes analyses.